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The  mitochondrial  permeability  transition  pore  (mPTP)  has long  been  known  to  have  a role  in  mito-
chondrial  calcium  (Ca2+) homeostasis  under  pathological  conditions  as  a mediator  of the  mitochondrial
permeability  transition  and  the activation  of the  consequent  cell  death  mechanism.  However,  its role
in  the  context  of mitochondrial  Ca2+ homeostasis  is not  yet  clear.  Several  studies  that  were  based  on
PPIF  inhibition  or knock  out  suggested  that  mPTP  is  involved  in the  Ca2+ efﬂux mechanism,  while  other
observations  have  revealed  the opposite  result.
The  c subunit  of  the mitochondrial  F /F ATP  synthase  has  been  recently  found  to be a fundamental
TP5G1
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itochondria
ermeability transition pore (PTP)
1 O
component  of  the  mPTP.  In this  work,  we  focused  on  the  contribution  of  the mPTP  in the  Ca2+ efﬂux
mechanism  by modulating  the  expression  of  the  c subunit.  We  observed  that forcing  mPTP  opening  or
closing  did  not  impair  mitochondrial  Ca2+ efﬂux.  Therefore,  our  results  strongly  suggest  that  the  mPTP
does  not  participate  in mitochondrial  Ca2+ homeostasis  in a physiological  context  in HeLa  cells.
© 2014  The  Authors.  Published  by  Elsevier  Ltd.  This  is  an  open  access  article  under the  CC  BY license
eptidyl prolyl isomerase F (PPIF)
. Introduction
Mitochondria are intracellular organelles involved in several
ellular functions such as ATP production, fatty acid oxidation,
a2+ signaling and cell death. [1–4]. Under pathological conditions,
itochondria are able to adapt by fusion or ﬁssion processes and
odulate respiratory substrate utilization to regulate ATP produc-
ion [5]. Furthermore, in cases of severe damage, mitochondria are
liminated by autophagy, and cell death can occur [6]. Thus, these
rganelles are master regulators of danger signaling [7,8].A key signaling messenger that is able to transduce life or
eath signals to mitochondria is intracellular Ca2+ [9,10]. The
itochondrial Ca2+ uptake and release mechanisms are based on
Abbreviations: ANT, adenine nucleotide translocase; [Ca2+]c, cytosolic calcium
oncentration; [Ca2+]m, mitochondrial calcium concentration; CsA, cyclosporine
; HK, hexokinase II; H2O2, hydrogen peroxide; IB, intracellular milieu; MCU,
itochondrial Ca2+ uniporter; NCLX, mitochondrial Na+/Ca2+ antiporter; MPT, mito-
hondrial permeability transition; mPTP, mitochondrial permeability transition
ore; PiC, inorganic phosphate carrier; PPIF, peptidyl prolyl isomerase; siRNAs,
mall-interfering RNAs; TSPO, peripheral benzodiazepine receptor; RuR, ruthenium
ed; VDAC, voltage-dependent anion channel.
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the utilization of gated channels for Ca2+ uptake and exchangers
for release that are dependent upon the negative mitochondrial
membrane potential, which represents the driving force for Ca2+
accumulation in the mitochondrial matrix [11]. The mitochondrial
Ca2+ uniporter (MCU), which is encoded by the recently discov-
ered gene ccdc109a [12,13], is responsible for Ca2+ inﬂux, while
the mitochondrial Na+/Ca2+ antiporter (NCLX) [14] is responsible
for Ca2+ efﬂux. In spite of this information, the mitochondrial Ca2+
efﬂux mechanism has not been completely elucidated. It is mostly
accepted that Na+/Ca2+ exchange activity is relevant for excitable
cells [15] and that NCLX inhibition or silencing does not completely
arrest Ca2+ efﬂux [14], which indicates that other mechanisms are
involved in this process. Two  mechanisms have been proposed to
supplement Ca2+ efﬂux, one based on the H+/Ca2+ antiporter [16]
and another based on the mitochondrial permeability transition
pore (mPTP) [17], but evidence supporting the latter remains elu-
sive.
The mPTP is a high-conductance channel that is located at
the contact sites between the inner and outer mitochondrial
membranes. This channel is responsible for the non-selective
permeability state of the mitochondrial inner membrane. The
transition to this state for small molecules is referred to as the
mitochondrial permeability transition (MPT). The molecular com-
position of the mPTP is not yet clear, but several proteins have
been shown to be components that participate in mPTP activity,
including voltage-dependent anion channels (VDAC) [18], adenine
nder the CC BY license (http://creativecommons.org/licenses/by/3.0/).
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ucleotide translocase (ANT) [19], the inorganic phosphate carrier
PiC), [20], peptidyl prolyl isomerase F (PPIF) [21,22], the peripheral
enzodiazepine receptor (TSPO) [23], hexokinase II (HK) [24] and
everal members of the Bcl-2 family [25–27].
Ca2+ ions, prooxidant and proapoptotic proteins, a decrease in
he mitochondrial membrane potential, pH variations and adenine
ucleotides all sensitize the opening of the pore [28,29].
MPT  resulting from mPTP opening is usually considered a trans-
ucer event in between Ca2+ or oxidative signal and different type
f cell death [3,30]. Nonetheless several observations have sug-
ested that mPTP is a component of the Ca2+ efﬂux mechanism
31–34] proposing a physiological role for this ambiguous com-
lex. Unfortunately a different amount of studies have proposed
he exact opposite [35,36] leaving this supposition still unresolved.
herefore, we focused on the role of the mPTP in mitochondrial
a2+ homeostasis under non-pathological conditions. Recently, we
uggested that, similar to PPIF, the c subunit of the FO ATP syn-
hase constitutes a critical component of the mPTP and that it is
equired for the MPT, mitochondrial fragmentation and cell death
nduced by oxidative stress or mitochondrial Ca2+ overload [37].
his concept was further conﬁrmed by two different groups after
ur publication [38,39] and recently reviewed in [40].
By modulating c subunit expression and using pharmacological
pproaches, we  revealed the important ﬁnding that the mPTP is not
ecessary for mitochondrial Ca2+ release; therefore, it does not par-
icipate in mitochondrial Ca2+ homeostasis in a non-pathological
ontext, at least in HeLa cells.
. Results
.1. Regulation of mPTP activity by modulating the expression of
he FO ATP synthase c subunit
To study the contribution of mPTP in mitochondrial Ca2+ homeo-
tasis, we have investigated the kinetics of the mitochondrial and
ytosolic Ca2+ inﬂux and efﬂux. We  have recently suggested that
he c subunit of the F1/FO ATP synthase is a component of the mPTP
hat is required for the MPT-driven mitochondrial fragmentation
hat is induced by cytosolic Ca2+ overload and oxidative stress [37].
herefore, we decided to modulate mPTP activity by genetically
anipulating the expression of the c subunit in the HeLa human
ervical carcinoma cell line. The mammalian ATP synthase c sub-
nit is encoded by three different nuclear genes (ATP5G1, ATP5G2
nd ATP5G3) that produce three different protein products. These
roducts differ in their mitochondrial localization sequence but
esult in the same mature protein after cleavage of the localization
eptide [41]. As previously shown, we used a mix  of three com-
ercially validated small-interfering RNAs (siRNAs) to silence the
hree different genes that code for the c subunit (ATP5G1, ATP5G2
nd ATP5G3). Analysis of the mRNA levels of the three genes using
eal-time PCR indicated that the silencing strategy resulted in an
pproximate reduction of 75% for ATP5G1, 53% for ATP5G2, and
0% for ATP5G3 (Fig. 1Ai), and western blot analysis showed that
he protein levels were reduced to nearly 70% of the total protein
evel (Fig. 1Aii). To monitor the effective state of the mPTP, we  used
he calcein-Co2+ assay during c subunit silencing (Fig. 1B). As previ-
usly reported, ATP5G silencing ablated mPTP activity and resulted
n increased ﬂuorescence of mitochondrial calcein (Fig. 1B).
By taking advantage of aequorin technology [42], we  ﬁrst mea-
ured the mitochondrial and cytosolic Ca2+ concentrations after
timulation with 100 M histamine in HeLa cells that were trans-
ected with a control siRNA (siSCR) or a mix  of siRNAs that targeted
TP5G1, ATP5G2 and ATP5G3 (siATP5G) for 48 h (Fig. 1C). Silenc-
ng of the c subunit caused a non-signiﬁcant reduction in Ca2+
ptake by the mitochondria (peak amplitude: 67.35 ± 4.41 M vs.cium 56 (2014) 1–13
71.08 ± 3.33 M [siSCR]; p > 0.05) and in the Ca2+ uptake rate,
but no signiﬁcant variations in the rate of Ca2+ release from the
mitochondria were observed (Fig. 1D). Furthermore, no signif-
icant differences in the cytosolic Ca2+ levels (peak amplitude:
2.13 ± 0.09 M vs. 2.32 ± 0.08 M [siSCR]; p > 0.05) (Fig. 1E) or in
the kinetics of Ca2+ inﬂux and efﬂux (Fig. 1F) were detected.
To conﬁrm the experimental method, mitochondrial Ca2+
dynamics were monitored in the presence of a well-established
blocker of the mitochondrial Ca2+ efﬂux system, CGP37157, which
is an inhibitor of the mitochondrial Na+/Ca2+ exchanger [43].
HeLa cells were exposed to CGP37157 (10 M)  for 2 min, and
Ca2+ uptake was induced with histamine (100 M)  in the continu-
ous presence of the inhibitor.
CGP37157 caused an expected increase in Ca2+ uptake
by the mitochondria (peak amplitude: 109.2 ± 15.52 M vs.
68.6 ± 6.81 M [Mock]; p < 0.05) (Fig. S1A) and a signiﬁcant
decrease of 31% in the rate of Ca2+ release from the mitochon-
dria due to inhibition of the mitochondrial Na+/Ca2+ exchanger (Fig.
S1B). The absence of signiﬁcant differences between the cytosolic
Ca2+ levels (peak amplitude: 2.84 ± 0.06 M vs. 2.77 ± 0.33 M
[siSCR]; p > 0.05) (Fig. S1C) and Ca2+ inﬂux and efﬂux kinetics (Fig.
S1D) conﬁrmed the speciﬁcity of CGP37157.
In our experimental settings, HeLa cells appeared to display
higher RNA levels of ATP5G1 compared to its homologs. We  thus
decided to overexpress a Myc-tagged ATP5G1, which was under
the control of the cytomegalovirus immediate early promoter, to
verify its effect on mitochondrial Ca2+ homeostasis.
Overexperession levels were assessed by Western blot and
results in dramatic increase in levels of c subunit (Fig. 2A). As
expected, ATP5G1 overexpression was sufﬁcient to induce the
opening of the mPTP, as conﬁrmed by the calcein-Co2+ assay
(Fig. 2B).
Overexpression of the c subunit induces a tendency in lower
the mitochondrial Ca2+ uptake (peak amplitude: 82.34 ± 5.4 M vs.
93.89 ± 10.6 M [Mock]; p > 0.05), without signiﬁcantly affect the
kinetics of Ca2+ inﬂux and efﬂux (Fig. 2C and D) or cytosolic Ca2+
levels (peak amplitude: 3.03 ± 0.08 M vs. 2.94 ± 0.07 M [siSCR];
p > 0.05) (Fig. 2E and F).
2.2. Modulation by pharmacological treatments of mPTP activity
in the regulation of mitochondrial Ca2+ inﬂux/efﬂux
To conﬁrm the absence of an effect of mPTP modulation on
Ca2+ efﬂux, we used a pharmacological approach; speciﬁcally,
Cyclosporine A (CsA) and hydrogen peroxide (H2O2) were used as
an inhibitor of the mPTP [44] and an inducer of mPTP opening,
respectively [45].
CsA (1 M)  was  added to HeLa cells 30 min  before stimulation
with histamine (100 M)  and measurements of [Ca2+]m. As pre-
viously reported [37], CsA induced a signiﬁcant increase in Ca2+
uptake (peak amplitude: 82.63 ± 2.82 M vs. 70.2 ± 2.65 M [vehi-
cle]; p < 0.05) (Fig. 3A) and in the rate of Ca2+ accumulation in the
mitochondria due to an increase in the mitochondrial membrane
potential, which is the driving force for Ca2+ accumulation. In con-
trast, no differences in Ca2+ efﬂux kinetics (Fig. 3B) were observed.
The closed state of the mPTP was  conﬁrmed using the calcein-Co2+
assay (Fig. 3C).
In contrast, to pharmacologically induce mPTP opening, HeLa
cells were exposed to H2O2 (500 M)  30 min  before stimula-
tion with histamine (100 M).  As expected, in the presence of
H2O2, a signiﬁcant decrease in Ca2+ uptake by the mitochondria
was induced (peak amplitude: 36.52 ± 3.34 M vs. 70.2 ± 2.65 M
[vehicle]; p < 0.001) (Fig. 3D).
Regarding the Ca2+ inﬂux/efﬂux kinetics, a signiﬁcant reduction
of 33% in the rate of Ca2+ accumulation into the mitochondria and
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Fig. 1. Calcium signaling during F1/FO ATP synthase c subunit silencing in HeLa cells. The mRNA relative aboundance of ATP5G1, ATP5G2 and ATP5G3 (Ai) and the protein
relative aboundance of ATP5G (Aii) after human cervical carcinoma (HeLa) cells transfection with a scrambled siRNA (siSCR) or a mix  of siRNAs targeting ATP5G1, ATP5G2
and  ATP5G3 (siATP5G) for 48 h (n = 3, independent experiments). Fluorescence intensity levels in the Calcein-Co2+ assay (B). HeLa cells were transfected as in (A) but in a
combination with a plasmid encoding a mitochondrial red ﬂuorescent protein (mtDsRED). These cells were monitored using ﬂuorescence microscopy to assess the Calcein
signal  (n = 250, cells from 3 independent experiments). HeLa cells were transfected as in (A) but in a combination with a plasmid coding for a mitochondrial (C) (n = 30, from 6
indipendent experiments) or cytosolic (E) (n = 10, from 3 indipendent experiments) aequorin and then stimulated with 100 M histamine (Hist). The rates of mitochondrial
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ID)  and cytosolic (F) Ca accumulation and release and a schematic representati
p  < 0.05,**p < 0.01.
 signiﬁcant reduction of 22% in the rate of Ca2+ release from the
itochondria in the presence of H2O2 (500 M)  occurred (Fig. 3E).
To conﬁrm the speciﬁcity of the effect of H2O2 on mPTP open-
ng and Ca2+ handling, we combined H2O2 (500 M) and CsA
1 M)  before stimulation with histamine (100 M)  (Fig. 4A).
n such conditions, histamine challenge resulted in a partialthe meaning of the indexes are shown. The data are presented as means ± SEM;
recovery of the [Ca2+]m (peak amplitude: 32.59 ± 5.79 M [vehicle]
vs. 51.6 ± 10.3 M [CsA]; p < 0.05) and uptake rate, while no signiﬁ-
cant reduction in the kinetics of Ca2+ efﬂux were observed (Fig. 4B).
Silencing of ATP5G resulted in protection of mPTP opening dur-
ing challenge with the prooxidant H2O2 to an extent comparable
with treatment with CsA [37]. As expected, HeLa cells depleted of
4 E. De Marchi et al. / Cell Calcium 56 (2014) 1–13
Fig. 2. Calcium signaling during F1/FO ATP synthase c subunit overexpression in HeLa cells. (A) The protein relative abundance of HeLa cells mock transfected or transfected
for  48 h with a plasmid encoding MYC-tagged ATP5G1 (n = 3, independent experiments). Fluorescence intensity levels in the Calcein-Co2+ assay (B) in Hela cells transfected
as  in (A) but in a combination with a plasmid encoding mtDsRED (n = 15, cells from 3 independent experiments). Mitochondrial (C) and cytoplasmic (E) Ca2+ peak in HeLa
cells  transfected as in (B), in a combination with a plasmid coding for a mitochondrial (C) (n = 16 from 4 indipendent experiments) or cytosolic (E) (n = 10, from 3 indipendent
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bxperiments) aequorin, and then, the cells were stimulated with 100 M histamin
ata  are presented as means ± SEM; **p  < 0.01.
TP5G displayed a [Ca2+]m that was protected from H2O2 in ampli-
ude (peak amplitude: 32.6 ± 5.79 M [siSCR] vs. 57.3 ± 4.96 M
siATP5G]; p < 0.01) and uptake speed, while no signiﬁcant differ-
nces were observed in the recovery phase of the peaks (Fig. 4C and
). In contrast, ATP5G1 overexpression resulted in the promotion
f H2O2-induced suppression of mitochondrial Ca2+ uptake (peak
mplitude: 47.9 ± 5.19 M [Mock] vs. 29.2 ± 2.22 M [ATP5G1];
 < 0.01), with a parallel inhibition of uptake and release kinetics
Fig. 4E and F).
Overall, the data show that the mPTP pharmacological opening
nversely correlate with the amplitude and inﬂux rate of [Ca2+]m,
ut does not affect efﬂux rates in living cells.t). Rates of mitochondrial (D) and cytosolic (F) Ca accumulation and release. The
2.3. Mitochondrial Ca2+ homeostasis and mPTP modulation
during saturation of calcium efﬂux system
Multiple authors have proposed that the mPTP exerts a signif-
icant effect on mitochondrial Ca2+ efﬂux only during saturation of
the Ca2+ export system [46]. To explore this, we  monitored the
effect of genetic manipulation of ATP5G by blocking the mitochon-
drial Na+/Ca2+ exchanger.As previously shown (Fig. S1), exposure to CGP37157 induced
a signiﬁcant increase in the [Ca2+]m during agonist stimulation
with a concomitant reduction of the efﬂux rate. If mPTP opening
extrudes Ca2+ only during the saturation of other efﬂux systems,
E. De Marchi et al. / Cell Calcium 56 (2014) 1–13 5
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Fig. 3. Modulation of the Ca2+ inﬂux/efﬂux rates by CsA or H2O2 treatment. HeLa cells were transfected with a plasmid coding for a mitochondrial targeted aequorin and
treated with 1 M CsA for 30 min. The cells were then stimulated with 100 M histamine (Hist) (A) (n = 16 from 4 independent experiments). Rates of mitochondrial (B) Ca2+
accumulation and release. (C) Fluorescence intensity levels in the Calcein-Co2+ assay of HeLa cells treated as in (A) but trasfected with a plasmid encoding a mitochondrial
red  ﬂuorescent protein (mtDsRED). The cells were monitored by ﬂuorescence microscopy to assess the Calcein signal (n = 25 cells from 3 independent experiments). HeLa
cells  were transfected with a plasmid coding for a mitochondrial aequorin and treated with 500 M H2O2 for 30 min  (D and E). The cells were then stimulated with 100 M
h rial (E
a ﬂuore
a sente
t
t
e
i
v
(
e
s
i
N
c
C
[
e
u
e
l
t
[
i
o
t
f
c
d
6istamine (Hist) (D) (n = 12, from 3 indipendent experiments). Rates of mitochond
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ssess  the calcein signal (n = 40, from 3 independent experiments). The data are pre
hen c subunit depletion should result in a strengthened inhibi-
ion of the efﬂux rate. However, silencing of ATP5G in HeLa cells
xposed to CGP37157 did not display any signiﬁcant differences
n peak amplitude (Fig. 5A, peak amplitude: 86.2 ± 17.2 M [siSCR]
s. 85.7 ± 15.93 M [siATP5G]; p > 0.05), uptake, or release speed
Fig. 5B) when compared with siSCR-treated cells.
An analogous situation was observed during ATP5G1 over-
xpression. We  proposed that ATP5G1 overexpression would
ensitize MPT  induction; therefore, the threshold for mPTP open-
ng should be reached faster when efﬂux systems are saturated.
onetheless, exposure to CGP37157 did not induce any signiﬁ-
ant variations in any of the measured indicators of mitochondrial
a2+ homeostasis (Fig. 5C and D, peak amplitude: 95.23 ± 12.44 M
Mock] vs. 81.27 ± 18.91 M [ATP5G1]; p > 0.05).
To avoid any aspeciﬁc effect related to modulation of ATP5G
xpression, the effect of efﬂux system saturation was tested
sing pharmacological inhibition of the mPTP by CsA. HeLa cells
xposed to GCP37157 displayed a peak amplitude that was much
ower than that in double-treated cells (Fig. 6A, peak ampli-
ude: 132.2 ± 29.53 M [CsA + CGP37157] vs. 75.84 ± 8.00 M
CGP37157]; p < 0.05). This ﬁnding was also reﬂected in a dramatic
ncrease in the uptake rate (Fig. 6B). Despite the different amounts
f available Ca2+, CsA did not induce the hypothesized reduction in
he efﬂux rate, but resulted in only a small increase (Fig. 6B).
Furthermore, as an alternative route to [Ca2+]m saturation, we
orced an increase in the [Ca2+]m by overexpressing the MCU. HeLa
ells overexpressing the mitochondrial Ca2+ uniporter displayed a
ramatic increase in mitochondrial Ca2+ uptake (peak amplitude:
2.74 ± 3.69 M vs. 112.14 ± 10.27 M [Mock]; p < 0.01), which) Ca2+ accumulation and release. Fluorescence intensity levels in the Calcein-Co2+
scent protein (mtDsRED). The cells were monitored by ﬂuorescence microscopy to
d as means ± SEM; *p < 0.05, **p  < 0.01, ***p < 0.001.
was near 100% (Fig. 6A). As expected, a signiﬁcant stimulation
of Ca2+ inﬂux was observed (approximately 97%); however, no
signiﬁcant variations in efﬂux were detected (Fig. 6B). MCUa over-
expression was  then combined with mPTP inhibition using CsA.
Cells that were exposed to CsA (1 M)  and overexpressing MCUa
tended to display a reduction in the maximal [Ca2+]m, (peak ampli-
tude: 112.2 ± 10.27 M [MCUa] vs. 98.9 ± 13.57 M [MCUa + CsA];
p > 0.05), which was in contrast to what was observed in mock-
transfected cells (Figs. 3A and 6C). Nonetheless, no differences were
detected in the Ca2+ efﬂux rates (Fig. 6D).
2.4. Effect of mPTP in mitochondrial Ca2+ homeostasis in
permeabilized cells
The efﬁciency of the mitochondrial Ca2+ efﬂux system has
been proposed to be dependent upon [Ca2+]m. Some previously
described conditions cause variations in the maximal [Ca2+]m. To
avoid data misinterpretation due to this effect, we  measured mito-
chondrial Ca2+ accumulation and release in permeabilized cells that
were exposed to the same [Ca2+]. For this purpose, HeLa cells were
perfused with a solution mimicking the intracellular milieu (IB)
supplemented with 2 mM EGTA, the cells were then permeabili-
zed with digitonin 30 M for 1 min. The perfusion buffer was  then
changed to IB, which had an EGTA-buffered [Ca2+] of 1 M.  The
cells were ﬁnally perfused with IB that was  supplemented with
Ruthenium Red (RuR), which is an inhibitor of the mitochondrial
Ca2+ uniporter, and deprived of free Ca2+ to induce a maximal rate
of Ca2+ release from the mitochondria. The same experiment was
performed during modulation of the expression of the c subunit
6 E. De Marchi et al. / Cell Calcium 56 (2014) 1–13
Fig. 4. Modulation of the mPTP activity in combination with H2O2 treatment. HeLa cells were transfected with a plasmid coding for a mitochondrial targeted aequorin,
treated  with 1 M CsA for 30 min  and then treated with 500 M H2O2 for 30 min  (A and B). The cells were then stimulated with 100 M histamine (Hist) (A) (n = 10, from 3
independent experiments). Rates of mitochondrial (B) Ca2+ accumulation and release. HeLa cells were transfected with a scrambled siRNA (siSCR) or a mix  of siRNAs targeting
ATP5G1, ATP5G2 and ATP5G3 (siATP5G) in a combination with a plasmid coding for a mitochondrial aequorin for 48 h and treated with 500 M H2O2 for 30 min  (C and
D).  The cells were then stimulated with 100 M histamine (Hist) (C). (n = 10, from 3 independent experiments). Rates of mitochondrial (D) Ca2+ accumulation and release.
HeLa  cells were mock transfected or transfected for 48 h with a plasmid encoding MYC-tagged ATP5G1 in a combination with a plasmid coding for a mitochondrial aequorin
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itochondrial Ca2+ accumulation and release (F). The data are presented as means 
r in the presence of CsA (1 M),  which was added 30 min  before
he beginning of the measurements. The exposure of permeabilized
ells transfected with scrambled siRNA to external [Ca2+] (1 M)
nduced a rapid increase in the [Ca2+]m that was stabilized at
 value of 3.09 ± 0.24, which was analogous to the [Ca2+]m that
as reached in cells transfected with siATP5G (Fig. 7A, plateau
.89 ± 0.22 M).  The switch to a Ca2+-free condition in the pres-
nce of RuR induced a dramatic decrease in the [Ca2+]m, and the
ate at which this occurred appeared to be identical between cells
ransfected with scrambled siRNA or depleted for ATP5G (Fig. 7B).
egligible variations in the plateau levels or Ca2+ efﬂux rates
ere also detected when overexpressing ATP5G1 (Fig. 7C and D,
lateau level: 2.03 ± 0.26 M [Mock] vs. 2.34 ± 0.43 M [ATP5G1];
 > 0.05) or during exposure to CsA (Fig. 7E and F, plateau level:
.72 ± 0.28 M [Vehicle] vs. 1.65 ± 0.74 M [CsA]; p > 0.05). Thish 100 M histamine (Hist) (E) (n = 10, from 3 independent experiments). Rates of
; *p < 0.05, ***p < 0.001.
ﬁnding conﬁrmed that the mPTP does not affect the maximal mito-
chondrial Ca2+ efﬂux rate at the standard [Ca2+]m.
Nonetheless, in such experimental conditions, a possible effect
of the mPTP on efﬂux kinetics could be overcome by the activity of
mNCX and the Ca2+/H+ antiporter. Therefore, the Ca2+ efﬂux rates
were monitored in the presence of the mitochondrial Na+/Ca2+
exchanger CGP37157 and were elicited by 2 M RuR and in the
presence of external Ca2+. CGP37157 dramatically increased mito-
chondrial Ca2+ uptake, causing fast aequorin consumption when
external Ca2+ 1 M was added ([Ca2+]m > 14 M data not show). In
this second group of permeabilized cells, Ca2+ uptake was elicited
by adding external Ca2+ (0.5 M).  Administration of RuR induced
slow (but not absent) Ca2+ release from the mitochondrial matrix
in scrambled, siRNA-transfected HeLa cells (Fig. 8). Interestingly,
cells transfected with siRNA for ATP5G1 displayed the same [Ca2+]m
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Fig. 5. Modulation of the mPTP activity by combined CGP37157 exposure and c subunit silencing or c subunit overexpression. HeLa cells were transfected with a scrambled
siRNA (siSCR) or a mix  of siRNAs targeting ATP5G1, ATP5G2 and ATP5G3 (siATP5G) in a combination with a plasmid coding for a mitochondrial aequorin for 48 h and treated
with  10 M CGP37157 added 2 min  before stimulation with histamine, which was done in the continuous presence of CGP37157 (A and B). The cells were then stimulated
with  100 M histamine (Hist) (A) (n = 10, from 3 independent experiments). Rates of mitochondrial Ca2+ accumulation and release (B). (C and D) HeLa cells were mock
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0  M CGP37157 added 2 min  before stimulation with histamine, which was done
istamine (Hist) (C) (n = 10, from 3 independent experiments). Rates of mitochondr
t the plateau (Fig. 8A), and efﬂux speed in the presence of RuR
Fig. 8B). In parallel, the efﬂux rate in HeLa cells overexpressing
TP5G1 display a bare, but not signiﬁcant, increase in Ca2+ efﬂux
ate (Fig. 8C and D). Finally when the cells were pretreated with
sA (Fig. 8E and F), the extrusion rate appeared to be completely
dentical to that measured in untreated cells, indicating that mPTP
as not responsible for the leakage of the remaining Ca2+ from the
itochondrial matrix.
. Discussion
Correct Ca2+ uptake into the mitochondria is essential for mito-
hondrial oxidative phosphorylation, but excessive Ca2+ uptake
eads to cell death [47]. Therefore, the balance between Ca2+ inﬂux
nd efﬂux is fundamental for correct intracellular homeostasis and
s extensively regulated by inﬂux (through the mitochondrial Ca2+
niporter) and efﬂux (through the Na+/Ca2+ or H+/Ca2+ exchanger)
ystems [35].
Some authors have proposed that the mPTP is a component
f the Ca2+ efﬂux system due to the non-speciﬁc channel prop-
rties that were observed during its opening [17,34]. These reports
re based mainly on pharmacological inhibition of the mPTP by
yclosporine A (CsA, which targets PPIF) or by knocking down PPIF,
hich causes typical alterations in mitochondrial Ca2+ homeosta-
is that could be associated with alterations in the mitochondrial
a2+ efﬂux (especially alterations in the maximal [Ca2+]m and Ca2+
xtrusion rates). On the other hand, several other reports havembination with a plasmid coding for a mitochondrial aequorin and treated with
e continuous presence of CGP37157. The cells were then stimulated with 100 M
 Ca2+ accumulation and release (D). The data are presented as means ± SEM.
indicated the opposite [35,36], which suggests a different function
for CsA in affecting Ca2+ homeostasis.
Driven by our recent work suggesting that the c subunit of the
F1/FO ATP synthase is a component of the mPTP, we have focused
our attention on the involvement of the mPTP in mitochondrial
Ca2+ homeostasis under non-pathological conditions. The novelty
of our study lies in the regulation of mPTP activity by manipulating
the c subunit of the F1/FO ATP synthase and measuring the [Ca2+]m
and [Ca2+]c using the pH-independent, luminescent, Ca2+-sensitive
probe, aequorin [42].
Measurements of the [Ca2+]m revealed a minimum reduction
in mitochondrial Ca2+ loading after c subunit silencing, but no
variations in the rate of Ca2+ release from the mitochondria were
observed. Furthermore, no changes in the cytosolic Ca2+ levels were
observed. As previously shown in this condition, we forced the
closing of the mPTP, and the cells were protected from damage.
An analogous situation occurred when the c subunit was over-
expressed, which forces the opening of the mPTP. In this case,
mitochondrial Ca2+ accumulation was  reduced, but no changes in
the rate of Ca2+ inﬂux or efﬂux occurred.
In both cases, the observed variations in peak amplitude cor-
related with a decrease in the mitochondrial membrane potential
that is induced by c subunit silencing or overexpression, which we
recently reported [37]. The overall modulation of c subunit expres-
sion suggested that, under physiological conditions in HeLa cells,
mPTP is not directly involved in the Ca2+ efﬂux mechanism, and an
indirect effect could be hypothesized instead.
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Fig. 6. Modulation of the mPTP activity by CSA treatment in combination with CGP37157 treatment or MCUa overexpression. HeLa cells were transfected for 48 h with
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nd  release (D). The data are presented as means ± SEM; *p < 0.05, ***p < 0.001.
We  previously reported that, in this cell line, c subunit silencing
enerates a moderate reduction of the MMP,  which is the opposite
f the signiﬁcant depolarization that occurs upon c subunit over-
xpression. Variations in the MMP,  which is the driving force for
a2+ accumulation in the mitochondrial matrix, could produce the
xact effects on the [Ca2+]m and uptake rate that were observed
n this model. To validate these results, we took advantage of
he well-known PPIF inhibitor CsA that was reported to be capa-
le of increasing the mitochondrial membrane potential (MMP)
nd [Ca2+]m [48,49]. After CsA treatment, a signiﬁcant increase in
itochondrial Ca2+ uptake and the peak amplitude occurred, but,
gain, no differences in the rate of mitochondrial Ca2+ efﬂux were
bserved (which was in accordance with the observation after c
ubunit silencing).
However, we cannot completely ignore the several respectable
eports proposing that there is an effect of the mPTP on mitochon-
rial Ca2+ efﬂux. Most of these reports were based on PPIF inhibition
r knock out. It could then be speculated that PPIF could some-
ow affect other participants of the Ca2+ efﬂux system, as proposed
y Wei  and co-workers [35], and possibly generate a conforma-
ional rearrangement upon interaction with other proteins due to
ts peptidyl-prolyl isomerase activity.
It could be argued that c subunit overexpression did not lead
o an mPTP opening event sufﬁcient to generate a detectable Ca2+
fﬂux. To test this hypothesis, we induced mPTP opening through
he use of the prototypic, pro-oxidant hydrogen peroxide. Expo-
ure to this stress agent results in mPTP opening with a consequent
eduction in the maximal [Ca2+]m after agonist exposure and an
ncrease in calcein quenching by cobalt. In this condition, a decreaseid coding for a mitochondria-targeted aequorin in absence or presence of 1 M CsA
 = 9, from 3 independent experiments). Rates of mitochondrial Ca2+ accumulation
in the mitochondrial Ca2+ inﬂux and efﬂux were observed, which
was in agreement with the reduced driving force, while an opened,
non-speciﬁc Ca2+ channel (such as the mPTP) should produce a
signiﬁcant increase in the Ca2+ efﬂux rate.
Nonetheless, although the [Ca2+]m was  partially recovered in
cells silenced for ATP5G or pretreated with CsA, protection from
the mPTP did not modify the kinetics of Ca2+ efﬂux. In contrast,
overexpression of ATP5G1 promoted H2O2-induced mPTP opening,
causing a further reduction in the maximal [Ca2+]m under agonist
stimulation. In spite of this reduction, the efﬂux rate did not display
a signiﬁcant stimulation, but rather a small inhibition. These obser-
vations provide strong conﬁrmation that, even following potent
induction of its opening, the mPTP does not participate in Ca2+
efﬂux. We  previously conﬁrmed that induction of the mPTP by
H2O2 caused slow MMP  dissipation (probably due to the induction
of the low conductance mode of mPTP) [37,50]. During protection
or induction of mPTP opening, the [Ca2+]m recovering phase seems
to correlate with the levels of MMP  previously observed in such
conditions [37], thus strengthening the hypothesis that a possible
modulation of the [Ca2+]m by the mPTP should indirectly occur due
to regulation of the MMP.
It was proposed that the effects of the mPTP on the kinetics of
Ca2+ efﬂux could be only relevant as a “safe valve” in mitochon-
dria with a saturated Ca2+ efﬂux system [46], which is analogous
to what was observed in the Ca2+ retention capacity experiments
that largely used isolated mitochondria to determine the threshold
for mPTP opening. To challenge this hypothesis in living cells, we
combined c subunit expression with blockade of the mitochondrial
Na+/Ca2+ antiporter through the use of CGP37157. Interestingly, all
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Fig. 7. Modulation of the mPTP activity by c subunit silencing, c subunit overexpression and CsA treatment in permeabilized cells. (A and B) HeLa cells were transfected
with  a scrambled siRNA (siSCR) or a mix  of siRNAs targeting ATP5G1, ATP5G2 and ATP5G3 (siATP5G) in a combination with a plasmid coding for a mitochondrial aequorin
for  48 h (n = 9, from 3 indipendent experiments). (C and D) HeLa cells were mock transfected or transfected for 48 h with a plasmid encoding MYC-tagged ATP5G1 in a
combination with a plasmid coding for a mitochondrial aequorin (n = 10, from 3 indipendent experiments). (E and F) HeLa cells were transfected with a plasmid coding for a
mitochondria-targeted aequorin and treated with 1 M CsA for 30 min  or vehicle (n = 10 from 3 indipendent experiments). The cells were then digitonin-permeabilized and
stimulated with 1 M [Ca2+] in EGTA-buffered buffer. Calcium efﬂux was stimulated by perfusion with a calcium-free buffer supplemented with Ruthenium Red (RuR). Rate
o 2+ 2+ ). The
t
i
u
s
m
i
d
a
s
hf  mitochondrial Ca release during Ca deprivation and RuR perfusion (B, D and F
he previously observed tendencies that were observed after silenc-
ng or overexpressing the c subunit were completely masked by the
se of CGP37157, suggesting that sustained [Ca2+]m levels are not
ufﬁcient to induce a calcium efﬂux through the mPTP. Further-
ore, an effect of on the [Ca2+]m was still observable as an increase
n the [Ca2+]m and inﬂux rate when blocking mNCX (characters
ependent on the MMP); nonetheless, the efﬂux rate was still not
ffected.
An alternative Ca2+ overload approach was proposed. Recently,
everal components of the mitochondrial Ca2+ uptake machinery
ave been revealed [51]. The core element of the MCU  system is data are presented as means ± SEM.
the product of the CCDC109a gene (MCUa [12,13]). Overexpressing
the MCUa, as expected, resulted in an extraordinary increase in the
Ca2+ inﬂux rate and [Ca2+]m. Such an increase was not further stim-
ulated by inhibition of the mPTP opening through treatment with
CsA, which suggested that the mitochondrial network was near its
maximal uptake capacity. Interestingly, MCUa overexpression also
resulted in a reproducible tendency to increase the Ca2+ efﬂux rate.
Treatment with CsA did not generate any signiﬁcant effects on the
calcium efﬂux rates of MCUa-overexpressing cells. Overall, these
results clearly indicate that overload of the [Ca2+]m in our cell model
is not sufﬁcient to induce a mPTP-dependent Ca2+ efﬂux.
10 E. De Marchi et al. / Cell Calcium 56 (2014) 1–13
Fig. 8. Modulation of the mPTP activity by combined CGP37157 and c subunit silencing, c subunit overexpression or CsA treatment in permeabilized cells. (A and B) HeLa
cells  were transfected with a scrambled siRNA (siSCR) or a mix  of siRNAs targeting ATP5G1, ATP5G2 and ATP5G3 (siATP5G) in a combination with a plasmid coding for a
mitochondrial aequorin for 48 h. (C and D) HeLa cells were mock transfected or transfected for 48 h with a plasmid encoding MYC-tagged ATP5G1 in a combination with a
plasmid coding for a mitochondrial aequorin (n = 12, from 3 indipendent experiments). (E and F) HeLa cells were transfected with a plasmid coding for a mitochondria-targeted
aequorin and treated with 1 M CsA for 30 min  or Vehicle (n = 9, from 3 indipendent experiments). The cells were then digitonin-permeabilized and stimulated with 0.5 M
[ was  st
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bCa2+] in EGTA-buffered buffer and in presence of CGP37157 10 M.  Calcium efﬂux 
uR  perfusion (B, D and F). The data are presented as means ± SEM.
The Ca2+ efﬂux system is dependent upon [Ca2+]m, which is
xposed; and modulation of the expression of the c subunit as well
s exposure to CsA results in alterations of the [Ca2+]m.
To avoid misinterpretation of the data due to different values for
he [Ca2+]m, Ca2+ efﬂux measurements were performed in perme-
bilized cells that had been stimulated with external Ca2+ (1 M)
o obtain a stable level of [Ca2+]m in the control mitochondria. After
hat plateau was reached, the external Ca2+ was removed, and the
CU  inhibitor Ruthenium Red was added to avoid Ca2+ reuptake.
he rate of Ca2+ release from the mitochondria under these con-
itions was considered the maximum efﬂux speed that could be
eached, and no signiﬁcant differences in the rate after mPTP inhi-
ition with CsA or during ATP5G silencing or its overexpressionimulated by 2 M Ruthenium Red (RuR). Rate of mitochondrial Ca2+ release during
were observed. It is reasonable to assume that because mitochon-
dria are energized by the addition of ADP, pyruvate, and succinate
in permeabilized cells, the efﬂux rate is driven mostly by the mNCX
and the H+/Ca2+ exchangers.
Nonetheless, further induction of efﬂux system saturation by
inhibiting the mitochondrial Na+/Ca2+ antiporter (in the presence
of external Ca2+) and MCU  (by RuR) generated a Ca2+ leak from the
mitochondrial matrix. This leak was independent of mPTP inhibi-
tion (by ATP5G silencing or CsA administration) and stimulation
(by ATP5G1 overexpression) and was thus ascribable only to the
H+/Ca2+ exchanger. These results exclude the possible involvement
of the mPTP as a component of the Ca2+ efﬂux system, even when
standardized Ca2+ concentrations where achieved.
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The presented results suggest that, in spite of what can be
bserved in isolated mitochondria, the mPTP has a Ca2+-induction
hreshold that is too high to be reached in living cells, and this
s most likely due to the high efﬁciency of the Na+/Ca2+ and
+/Ca2+ exchangers, which can could compete with and overcome
he mPTP. It should also be considered that the Ca2+ efﬂux from
itochondria is an energetically unfavorable process due to the
trong electrochemical gradient, which is negative in the matrix.
his allows for passive import into the matrix, as occurs during
CU. If the current model for the mPTP, which states that it forms
 nonspeciﬁc channel, is correct, then its partial opening, even in
he presence of reduced MMP  (as it apparently occurs in its low-
onductance mode), should favor import instead of efﬂux. In con-
rast, efﬂux through a channel would be expected on de-energized
itochondria, as was reported for the MCU  [52]. Still has to be
onsidered that inhibition of mPTP induce increase in Ca2+ loading
apacity that can lead to generation of toxic Ca2+ phosphorous rich
recipitates [53]. Present results do not exclude mPTP participation
n this phenomenon, but it would suggest that it could be indirectly
nvolved. Opening of mPTP do not directly allow Ca2+ transport, but
ather would dissipated mitochondrial membrane potential facili-
ating Ca2+ efﬂux by inverse transportation through MCU.
Altogether, these data demonstrate that, under physiological
onditions, the mPTP is a dispensable element for mitochondrial
a2+ homeostasis and, especially, for mitochondrial Ca2+ release at
east in our cell model.
. Materials and methods
.1. Chemicals, cell cultures and transfection
Human cervical carcinoma HeLa cells were maintained in a
umidiﬁed 5% CO2, 37 ◦C incubator in Dulbecco’s modiﬁed Eagle’s
edium (DMEM) supplemented with 10% fetal bovine serum (FBS),
00 U/ml penicillin (EuroClone, 3001D), 100 g/ml streptomycin
EuroClone, 3000D).
RNA interference experiments were performed by transfect-
ng cells with a commercial control siRNA (AllStars RNAi Controls,
erein referred to as siSCR), with a mix  of siRNAs targeting ATP5G1
5′-GCU CUG AUC CGC UGU UGU AdTdT-3′), ATP5G1 (5′-CGG AGA
AC UGA CAG AUG AdTdT-3′) and ATP5G3 (5′-AGG GCU CUA CGG
AU UUA AdTdT-3′), all purchased from Qiagen. siRNAs were trans-
ected by means of the HiPerfect® transfection reagent, as per
anufacturer’s instructions [54].
For transient overexpression experiments, a pCMV6 entry-
ased plasmid coding for a MYC-tagged variant of ATP5G1 under
he control of the CMV  immediate early promoter (RC200292) was
btained from OriGene, A pcDNA3 based plasmid coding for MCU-
ag tagged was gift from prof. Rosario Rizzuto from University of
adua, pcDNA3 empty vector was used as Mock. Plasmid transfec-
ions were performed via the standard Ca2+ phosphate procedure
55].
.2. RNA extraction and gene expression analyses
For the expression analysis of ATP5G1, ATP5G2, and ATP5G3
ilencing, total RNA was  puriﬁed from HeLa cells transfected with
crambled or ATP5G1 siRNAs (siATP5G1, 2 and 3), for 48 h follow-
ng the standard TRIzol protocol. To analyze mRNA expression,
RT-PCR was performed on 500 ng of total RNA using oligo dT (Fer-
entas) and random primers (Gibco). Quantitative PCR reaction
as performed using Qiagen Taq DNA Polymerase and EvaGreen
Biotium Inc.). The following oligonucleotides were used as primers
or the qPCR reaction: ATP5G1-fw, 5′-GCTGAGACCAAGGGCTAAAG-
′; ATP5G1-rv, 5′-CGGATCAGAGCTGGAGAAATG-3′; ATP5G2-fw,cium 56 (2014) 1–13 11
5′-TGGAACTGTGTTTGGGAGC-3′; ATP5G2-rv, 5′-TGGCAAAGAGGAT
GAGAAAGG-3′; ATP5G3-fw, 5′-TGGTTCTGGTGCTGGTATTG-3′;
ATP5G3-rv, 5′-GAGACCCATAGCTTCAGACAAG-3′.
Reactions were incubated in a 96-well PCR plate at 95 ◦C for
15 min, followed by 40 cycles of 95◦ C for 30 s and 58 ◦C for 1 min,
on Bio-Rad-Chromo4 Real Time thermal Cycler.
(available at http://ﬁji.sc/) and the parallel iterative deconvo-
lution plugin.
5. Western blot
48 h after transfection cells were washed, harvested and lysed
in RIPA buffer (50 mM Tris–HCl pH 7.8, 150 mM NaCl, 1% IGEPAL
CA-630, 0.5% sodium deoxycholate, 0.1% SDS, 1 mM DTT) sup-
plemented with proteases and phosphatases inhibitors (2 mM
Na3VO4, 2 mM NaF, 1 mM PMSF and Protease Inhibitor Cocktail).
Proteins were quantiﬁed using the Bradford Protein Assay (Bio-
Rad), and separated on Novex NuPage Bis–Tris 4–12% precast
gel (Invitrogen) and transferred to PVDF (BioRad) membranes for
standard western blotting.
Immunoblotting of the membranes was  performed using the
following primary antibodies: anti-ATP synthase C antibody (1:300,
Abcam) and anti-actin (1:5000, Sigma–Aldrich). Signals were
revealed after incubation with recommended secondary antibody
coupled to peroxidase by using enhanced chemiluminescence.
5.1. Aequorin measurements
Probes used are chimeric aequorins targeted to the cytosol
(cytAEQ) and mitochondria (mtAEQmut). “AEQ” refers to wild-type
aequorin, and “AEQmut” refers to a low afﬁnity D119A mutant of
aequorin. For the experiments with cytAEQ and mtAEQmut, cells
were incubated with 5 mM coelenterazine (Fluka, 7372) for 1–2 h
in Krebs–Ringer buffer (KRB). A coverslip with transfected cells
was placed in a perfused thermostated chamber located in close
proximity to a low-noise photomultiplier with a built-in ampli-
ﬁer/discriminator.
All aequorin measurements were performed in KRB supple-
mented with 1 mM CaCl2. Agonist was added to the same medium
as speciﬁed in ﬁgure legends. All experiments were terminated
by lysing cells with 100 M Triton in a hypotonic Ca2+-containing
solution (10 mM CaCl2 in H2O) thus discharging the remaining
aequorin pool. The output of the discriminator was captured by a
Thorn EMI  photon-counting board and stored in an IBM-compatible
computer for further analyses. The aequorin luminescence data
were calibrated ofﬂine into [Ca2+] values using a computer algo-
rithm based on the Ca2+ response curve of wild-type and mutant
aequorins.
In the experiments with permeabilized cells, a buffer mimick-
ing the cytosolic ionic composition, (intracellular buffer) was used:
130 mM KCl, 10 mM NaCl, 2 mM K2HPO4, 5 mM succinic acid, 5 mM
malic acid, 1 mM MgCl2, 20 mM HEPES, 1 mM pyruvate, 0.5 mM ATP
(pH 7 at 37 ◦C). Intracellular buffer was  supplemented with 2 mM
EGTA and 2 mM HEDTA-buffered [Ca2+] 1 M or 0.5 M (intra-
cellular buffer/Ca2+), calculated with the Chelator software [56].
HeLa cells were permeabilized by a 1-min perfusion with 50 M
digitonin (added to intracellular buffer/EGTA) during luminescence
measurements. Mitochondrial Ca2+ uptake rate was calculated as
the ﬁrst derivative by using Microsoft Excel (Microsoft Co.); all the
slopes were calculated at the same [Ca2+]m to ensure comparable
activity of efﬂux system.5.2. Calcein-Co2+ assays
At day one HeLa Cells were seeded on 25 mm glass coverslip.
After 24 h were transfected with Hyperfect or standard Ca2+
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hosphate procedure as previously described, a plasmid coding for
tDsRed was added to the transfection for all procedures. After 36 h
f expression HeLa were loaded with 1 mM Calcein acetoxymethyl
ster and Co2+ as instructed by the Image-IT® LIVE Mitochondrial
ransition Pore Assay Kit (Molecular Probes-Life Technologies).
ells were then imaged by means of 490 ± 20 nm excitation and
25 nm long pass emission ﬁlters on a Axiovert 200 M ﬂuorescence
icroscope equipped with a 40× water immersion objective
N.A. 1.2, from Carl Zeiss). Finally, images were analyzed with a
ustom Cell Proﬁler pipeline (http://www.cellproﬁler.org/), brieﬂy,
fter a background normalization Calcein average intensity was
alculated over the mtDsRed mask.
.3. Statistical procedures
Data were expressed as the mean ± SEM and were analyzed
ith Microsoft Excel (Microsoft Co.). Statistical signiﬁcance was
etermined by means of ANOVA followed by two-tailed unpaired
tudent’s t-tests. p values < 0.05 were considered statistically sig-
iﬁcant.
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